Coram is now the exclusive provider of Synribo (omacetaxine mepesuccinate).
In October 2012, the U.S. Food and Drug Administration (FDA) approved Synribo to treat adults with chronic or accelerated phase chronic myelogenous leukemia (CML), a blood and bone marrow disease, with resistance and/or intolerance to two or more tyrosine kinase inhibitors.
At Coram, we can provide your patients with the coordinated care and at-home nursing support needed to start and stay on Synribo.
Simply e-Prescribe, phone or fax your prescription to Coram – it’s that easy. If faxing, include a copy of the patient’s medical and prescription ID cards.
e-Prescribe: 241662 | Phone: 1-844-SYNCare (1-844-796-2273)
Fax: 1-855-SYNRIBO (1-855-796-7426) | Questions? Please call 1-844-SYNCare